LMRI Revenue Flow
Filed revenue amounts for 2026-04-01 to 2026-06-30. Coverage is partial. Unconnected amounts are separate disclosures; they must not be added together.
- 2026-06-30: Revenue $264.16M; Operating expenses $259.74M; Income tax $3.02M; Net income $2.75M.
- 2026-03-31: Revenue $252.54M; Operating expenses $248.15M; Income tax $1.36M; Net income $1.72M.
- 2025-06-30: Revenue $251.40M; Operating expenses $240.25M; Income tax $4.81M; Net income -$7.23M.
- 2025-03-31: Revenue $245.00M; Operating expenses $234.78M; Income tax $3.38M; Net income -$7.69M.
Consolidation item
Separate filed amounts; connecting flows are not established. Components and totals may overlap.
Product or service
Separate filed amounts; connecting flows are not established. Components and totals may overlap.
Related Party Transactions By Related Party
Separate filed amounts; connecting flows are not established. Components and totals may overlap.
Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.
Historical revenue and expense breakdown
Revenue and expense 3 month
| Period end | Revenue | Operating expenses | Income tax | Net income |
|---|---|---|---|---|
| 2026-06-30 | $264.16M | $259.74M | $3.02M | $2.75M |
| 2026-03-31 | $252.54M | $248.15M | $1.36M | $1.72M |
| 2025-06-30 | $251.40M | $240.25M | $4.81M | -$7.23M |
| 2025-03-31 | $245.00M | $234.78M | $3.38M | -$7.69M |
Revenue and expense 6 month
| Period end | Revenue | Operating expenses | Income tax | Net income |
|---|---|---|---|---|
| 2026-06-30 | $516.70M | $507.89M | $4.38M | $4.46M |
| 2025-06-30 | $496.40M | $475.03M | $8.19M | -$14.91M |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B |